Your cells use the CSDE1 gene to control how RNA messages are turned into proteins, which matters a great deal for brain development. When this gene does not work well, cells can lose some control over those protein levels. This gene plays an important role in how the brain develops and supports learning, speech, and behavior. People with harmful variants in the CSDE1 gene may have developmental delay, speech and language difficulties, intellectual disability, and sometimes autism features or seizures.
What is a gene?
A gene is a stretch of DNA that gives your cells instructions they can use to make molecules or regulate activities in the body. Some genes provide the directions for producing proteins, which are the parts of cells that do much of the work. Others mainly guide when, where, and how strongly certain activities take place. Taken together, genes affect how the body grows and works, and they can influence how you respond to food, stress, or medicines. More detail is available in the LearnHub.
Overview
CSDE1Gene function
What if the gene works
Your cells use the CSDE1 gene to help control how genetic messages are read and how much protein gets made. This supports steady cell growth and normal brain development.
Risk
What if the gene does not work
Variants in the CSDE1 gene are linked to a neurodevelopmental condition that often affects speech, learning, behavior, and social communication, sometimes with seizures. Milder and more severe variants can lead to different ages of onset and different symptom patterns.
Treatment
What does that mean for your treatment
No CSDE1-specific treatment or management approach is currently established. No drug choices are currently guided by a pathogenic variant in the CSDE1 gene. The CSDE1 gene is being studied in cancer biology as a possible biomarker and drug target, but this has not led to guideline-based care.
Gene function
What if the gene works
Your cells use the CSDE1 gene to manage RNA, the short-lived copies of genetic instructions used to make proteins. Its protein helps decide when selected messages are read, held back, or cleared away. This everyday control is a big part of what the CSDE1 gene does in cells.
The CSDE1 gene makes a protein that attaches to selected RNA messages. This lets cells recognize which instructions need extra control at a given moment.
By binding RNA, this gene helps control when some proteins are made. That timing supports steady cell activity and helps cells adjust protein output to everyday needs.
This gene also helps set how long certain RNA messages remain available before cells clear them away. That balance helps keep protein levels in a useful range.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These differences are common and are part of normal human diversity, such as variation in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, however, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many variants in the CSDE1 gene weaken how well its RNA binding protein can attach to RNA targets and control when other proteins are made in the cell. Some changes shorten the protein or reduce how much of it is produced, while others alter its shape and make it less stable or less active. This range helps explain CSDE1 gene variant effects: milder variants may leave partial function, while more disruptive variants can cause a larger loss of activity. In people with pathogenic variants, greater loss of function is often linked to earlier or broader neurodevelopmental features.
How variants are linked to conditions
Pathogenic variants in the CSDE1 gene can cause a neurodevelopmental condition with developmental delay, speech and language difficulties, intellectual disability, and autism spectrum features. In medical genetics, CSDE1 gene variants linked to developmental delay and autism spectrum disorder are the main well-established association. Some people also have seizures, attention or behavior differences, or mild differences in facial appearance.
A variant is not necessarily a diagnosis
Genetic variants are a normal and common feature of human biology. Most have no direct impact on health and simply reflect natural variation among people. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when more than one gene and environmental factors are involved. In some situations, though, a single well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risks related to the CSDE1 gene. For many living with a CSDE1 gene change, the main driver of risk appears to be the gene change itself rather than lifestyle or environmental factors, and a doctor or genetic counselor can help explain personal risk.
Inheritance of CSDE1 variants
For CSDE1-related conditions, the inheritance pattern is generally autosomal dominant, which helps answer how CSDE1 gene variants are inherited in families. This means one altered copy of the CSDE1 gene can be enough to cause the condition. If a parent carries a disease-causing CSDE1 gene variant, each child has a 50% chance of inheriting it. Some people have a new, de novo variant in the CSDE1 gene, meaning it started in them and was not inherited from either parent.
What does my CSDE1 result mean for my family?
For CSDE1, the main recognized condition is usually passed in an autosomal dominant pattern, so close relatives such as parents, brothers, sisters, and children may also carry the same gene change. In some families, an affected parent can pass it on, while in others the change is new in the child and not found in either parent. Because of that, what this means for relatives depends on whether the variant was inherited or happened for the first time.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a change in the CSDE1 gene, doctors use genetic testing for CSDE1 variants, usually on a blood or saliva sample. A lab reads the gene's DNA sequence and compares it with the usual sequence to look for variants. Results may show a pathogenic variant, a benign variant, or a variant of uncertain significance.
When should I consider getting a genetic test?
Genetic testing that includes the CSDE1 gene may be considered when a child has unexplained developmental delay, speech delay, learning problems, autism, or seizures, especially if more than one family member is affected. A result can sometimes help explain the cause and guide family counseling.
A genetic result is only one part of your health story
A genetic finding can be informative, but how much it explains depends on the condition and the specific type of variant. Over time, the body is shaped by many factors, including lifestyle, environment, age, and medical history. In some conditions, particularly those affected by many genes, genetic information offers context rather than certainty and is most useful when viewed together with other parts of care. In other situations, a genetic result may give a clear answer. For medication response, genetic results can also help put personal experiences in perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the body, or responds to it at its target. This helps explain why the same treatment works well for one person, works less well for another, or causes more side effects in someone who is more sensitive to it.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can shape a person’s response to medications. It studies gene and drug patterns to help explain why the same treatment may work differently from one person to another. For many medicines, genes can affect how strongly a drug works or how the body processes it. This information can support more informed, individualized treatment decisions. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the CSDE1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose. If you have concerns about side effects, how well a medicine is working, or any change in treatment, talk with your doctor or pharmacist.
History
CSDE1 entered the scientific literature in the 1990s, when researchers studying proteins that attach to RNA identified it under the earlier name UNR. It drew attention in part because it sits close to the NRAS gene on chromosome 1, which helped place it within a well-studied stretch of human DNA. Over time, descriptions became more precise. As work on RNA control expanded, the gene was renamed CSDE1 to reflect its cold shock domain structure, bringing its name in line with modern genetics. In later years, studies linked changes in the CSDE1 gene to neurodevelopmental conditions and some cancers, which gave the gene a clearer place in medical genetics.